NIH-funded research R01 grant

Plasmon-Enhanced Chiroptical Spectroscopy to Study Membrane-Binding Proteins

Official title: UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins

Funded at Boston University (Charles River Campus) · NIH-11404082 · Data updated 2026-11-12

A research project aims to make advanced light-based methods more sensitive so scientists can learn how membrane-binding proteins behave in their natural environment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University (Charles River Campus)
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 23, 2023
Project endJuly 31, 2027
Funding year2026
Award (this year)$346,500
NIH project number5R01GM150225-04
Project IDNIH-11404082 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable; this is a laboratory technique development project, not a patient study.

Less likely to help

No direct patient participation or benefit at this stage.

What this research studies

This project focuses on improving two light-based techniques, CD and ROA, to study membrane-binding proteins without needing special sample prep. By designing plasmonic nanostructures, the team hopes to boost signal strength and reduce how much sample is needed. The goal is to obtain clearer structural information about how these proteins interact with cell membranes under physiological conditions. The work could make these powerful measurements more accessible for understanding protein function in health and disease.

Why it matters

Potential benefit: If successful, this research could enable faster and more precise analysis of membrane-binding proteins, supporting drug development and better understanding of cellular signaling.

How similar studies have gone: Previous efforts have shown that plasmonic enhancements can increase signals, but applying them to membrane-binding protein spectroscopy is still being developed.

Where this research is happening

  • Boston University (Charles River Campus)
    Boston, United States
    Active

Researchers

  • Principal investigator: Reinhard, Bjoern Markus — Boston University (Charles River Campus)
  • Study coordinator: Reinhard, Bjoern Markus

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.